Biotech Values

[genisi]

UTHR FREEDOM-M study:

As I have posted (on the PLX board), having 21 extra patients seemed too little to me. Adding 100 more, so the majority (~150) of patients will have access to the 0.25mg pill, makes a p-value of 0.01 in this trial achievable, imo.

On MS, this one has a summery:

http://emedicine.medscape.com/article/1146199-treatment